|
🐜
|
Interleukin 12–mediated Prevention of Spontaneous Mammary Adenocarcinomas in Two Lines of Her-2/neu Transgenic Mice
17 auth.
K. Boggio,
G. Nicoletti,
E. Di Carlo,
F. Cavallo,
L. Landuzzi,
C. Melani,
M. Giovarelli,
I. Rossi,
P. Nanni,
C. De Giovanni,
...
P. Bouchard,
S. Wolf,
A. Modesti,
P. Musiani,
P. Lollini,
M. Colombo,
G. Forni
|
8 |
1998 |
8
🐜
|
|
🐜
|
Antitumor activity of the insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 in musculoskeletal tumors.
13 auth.
K. Scotlandi,
M. Manara,
G. Nicoletti,
P. Lollini,
S. Lukas,
S. Benini,
S. Croci,
S. Perdichizzi,
D. Zambelli,
M. Serra,
...
C. García-echeverría,
F. Hofmann,
P. Picci
|
8 |
2005 |
8
🐜
|
|
🐜
|
Combined Allogeneic Tumor Cell Vaccination and Systemic Interleukin 12 Prevents Mammary Carcinogenesis in HER-2/neu Transgenic Mice
14 auth.
P. Nanni,
G. Nicoletti,
C. De Giovanni,
L. Landuzzi,
E. Di Carlo,
F. Cavallo,
S. Pupa,
I. Rossi,
M. Colombo,
C. Ricci,
...
A. Astolfi,
P. Musiani,
G. Forni,
P. Lollini
|
8 |
2001 |
8
🐜
|
|
🐜
|
Blockage of insulin-like growth factor-I receptor inhibits the growth of Ewing's sarcoma in athymic mice.
10 auth.
K. Scotlandi,
S. Benini,
P. Nanni,
P. Lollini,
G. Nicoletti,
L. Landuzzi,
...
M. Serra,
M. Manara,
P. Picci,
N. Baldini
|
7 |
1998 |
7
🐜
|
|
🐬
|
TS/A: a new metastasizing cell line from a BALB/c spontaneous mammary adenocarcinoma
P. Nanni,
C. Giovanni,
P. Lollini,
G. Nicoletti,
G. Prodi
|
7 |
1983 |
7
🐬
|
|
🐜
|
CD99 inhibits neural differentiation of human Ewing sarcoma cells and thereby contributes to oncogenesis.
13 auth.
A. Rocchi,
M. Manara,
M. Sciandra,
D. Zambelli,
Filippo Nardi,
G. Nicoletti,
C. Garofalo,
S. Meschini,
A. Astolfi,
M. Colombo,
...
S. Lessnick,
P. Picci,
K. Scotlandi
|
7 |
2010 |
7
🐜
|
|
🐜
|
NVP-BEZ235 as a New Therapeutic Option for Sarcomas
12 auth.
M. Manara,
G. Nicoletti,
D. Zambelli,
S. Ventura,
C. Guerzoni,
L. Landuzzi,
...
P. Lollini,
S. Maira,
C. García-echeverría,
M. Mercuri,
P. Picci,
K. Scotlandi
|
7 |
2010 |
7
🐜
|
|
🐜
|
Preclinical In vivo Study of New Insulin-Like Growth Factor-I Receptor–Specific Inhibitor in Ewing's Sarcoma
11 auth.
M. Manara,
L. Landuzzi,
P. Nanni,
G. Nicoletti,
D. Zambelli,
P. Lollini,
...
C. Nanni,
F. Hofmann,
C. García-echeverría,
P. Picci,
K. Scotlandi
|
7 |
2007 |
7
🐜
|
|
🐜
|
Efficacy of and resistance to anti-IGF-1R therapies in Ewing's sarcoma is dependent on insulin receptor signaling
12 auth.
C. Garofalo,
M. Manara,
G. Nicoletti,
M. Marino,
P. Lollini,
A. Astolfi,
...
G. Pandini,
J. López-Guerrero,
K. Schaefer,
A. Belfiore,
P. Picci,
K. Scotlandi
|
7 |
2011 |
7
🐜
|
|
🐜
|
Effectiveness of insulin-like growth factor I receptor antisense strategy against Ewing's sarcoma cells
12 auth.
K. Scotlandi,
Cecilia Maini,
M. Manara,
S. Benini,
M. Serra,
V. Cerisano,
...
R. Strammiello,
N. Baldini,
P. Lollini,
P. Nanni,
G. Nicoletti,
P. Picci
|
6 |
2002 |
6
🐜
|
|
🐜
|
Immunoprevention of Mammary Carcinoma in HER-2/neu Transgenic Mice Is IFN-γ and B Cell Dependent1
12 auth.
P. Nanni,
L. Landuzzi,
G. Nicoletti,
C. De Giovanni,
I. Rossi,
S. Croci,
...
A. Astolfi,
M. Iezzi,
E. Di Carlo,
P. Musiani,
G. Forni,
P. Lollini
|
6 |
2004 |
6
🐜
|
